163 related articles for article (PubMed ID: 16949709)
21. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
[TBL] [Abstract][Full Text] [Related]
22. Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.
Greenwood DL; Dynon K; Kalkanidis M; Xiang S; Plebanski M; Scheerlinck JP
Vaccine; 2008 May; 26(22):2706-13. PubMed ID: 18448209
[TBL] [Abstract][Full Text] [Related]
23. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
[TBL] [Abstract][Full Text] [Related]
24. Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract.
Chen L; Lin T; Zhang H; Su Y
Intervirology; 2005; 48(4):207-12. PubMed ID: 15920343
[TBL] [Abstract][Full Text] [Related]
25. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
26. Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus--importance of dominant and subdominant epitopes for antigenicity and protection.
Frimann TH; Barfoed AM; Aasted B; Kamstrup S
Vaccine; 2007 Aug; 25(33):6191-200. PubMed ID: 17640782
[TBL] [Abstract][Full Text] [Related]
27. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
[TBL] [Abstract][Full Text] [Related]
28. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
[TBL] [Abstract][Full Text] [Related]
29. Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.
Yang Y; Teng Z; Lu Y; Luo X; Mu S; Ru J; Zhao X; Guo H; Ran X; Wen X; Sun S
Res Vet Sci; 2021 May; 136():89-96. PubMed ID: 33592449
[TBL] [Abstract][Full Text] [Related]
30. Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs.
Choudary S; Ravikumar P; Ashok Kumar C; Suryanarayana VV; Reddy GR
Virus Genes; 2008 Aug; 37(1):81-7. PubMed ID: 18516668
[TBL] [Abstract][Full Text] [Related]
31. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
32. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
33. Cationic microparticle [poly(D,L-lactide-co-glycolide)]-coated DNA vaccination induces a long-term immune response against foot and mouth disease in guinea pigs.
Reddy KS; Rashmi BR; Dechamma HJ; Gopalakrishna S; Banumathi N; Suryanarayana VV; Reddy GR
J Gene Med; 2012 May; 14(5):348-52. PubMed ID: 22438260
[TBL] [Abstract][Full Text] [Related]
34. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
[TBL] [Abstract][Full Text] [Related]
35. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
[TBL] [Abstract][Full Text] [Related]
36. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
37. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.
Shi XJ; Wang B; Wang M
Vaccine; 2007 Jan; 25(7):1257-64. PubMed ID: 17084491
[TBL] [Abstract][Full Text] [Related]
38. Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs.
Dory D; Rémond M; Béven V; Cariolet R; Backovic M; Zientara S; Jestin A
Antiviral Res; 2009 Mar; 81(3):217-25. PubMed ID: 19103226
[TBL] [Abstract][Full Text] [Related]
39. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
40. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
